Written by Christina Jensen on June 12, 2018
Have you ever wondered how pharmaceutical companies are encouraged to develop therapies for rare diseases? And whether or not this system is working?
We will cover these topics and more in an educational webinar on June 12. Join us as NORD’s Director of Federal Policy Paul Melmeyer discusses the… Read More